Clinical Trials
🇺🇸 FDA Page 8FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Access global clinical trial data, regulatory updates, and competitive intelligence for strategic pharma R&D and investment decisions.
Showing 85–96 of 380 articles
Fulcrum Therapeutics Stock Plummets 54% Following Sickle Cell Drug Discontinuation
Tenaya Therapeutics to Present TN-201 Gene Therapy Data for HCM on June 3, 2026
Fulcrum Explores Sale Amid FDA Setback for Sickle Cell Drug
Celcuity's Gedatolisib Trial Misses Expectations, Highlighting PIK3CA Inhibitor Challenges
This Week’s Biopharma News: New Approvals, Appeals, and AI
Navigating FDA's Clinical Trial Transparency Enforcement: A Practical Guide for Sponsors and Sites Post-April 2026
Eli Lilly issues data sharing ultimatum to 340B hospitals
New Radiopharmaceutical Shows Promise in Post-Pluvicto Setting, Offering Competitive Insights
STAT+: Longevity startup NewLimit raises $435 million ahead of first clinical trial
Inventiva's Strategic Capital Structure: A Deep Dive for Investors and Analysts
FDA Clears Iovance IL-12 TIL Trial, Signaling New Frontier in Solid Tumor Therapy
Abivax Stock Plummets Amid Safety Concerns in Ulcerative Colitis Trial